Skip to main content
OpenTrials
Completed

NCT Number: NCT03074604

Carbon Dioxide Surgical Field Flooding and Aortic No-touch Off-pump Coronary Artery Bypass Grafting to Reduce Neurological Injuries After Surgical Coronary Revascularization (CANON): a Randomised, Controlled, Investigator and Patient Blinded Single Center Superiority Trial With Three Parallel Arms.

The objective of this study is to investigate the value of employing the aortic no-touch off-pump coronary artery bypass technique and the practice of carbon dioxide surgical field flooding for the prevention of type 1 and 2 neurological injuries following surgical coronary revascularization.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Neurological injuries remain a major concern following coronary artery bypass grafting (CABG) that offset survival benefit of CABG over percutaneous coronary interventions. Among numerous efforts to combat this issue, is off-pump CABG (OPCABG) that obviates the need for extracorporeal circulation and is associated with improved outcomes. The objective of this study is to examine whether the neuroprotective effect of OPCABG can be further pronounced by the use of two state-of-the-art operating techniques.

In this randomised, controlled, investigator and patient blinded single center superiority trial with three parallel arms a total of 360 patients will be recruited. They will be allocated in a 1:1:1 ratio to two treatment and one control arms. Treatment arms undergoing either aortic no-touch OPCABG or OPCABG with a partial clamp applying carbon dioxide surgical field flooding will be compared against control arm undergoing OPCABG. The primary endpoint will be the appearance of new lesions on control brain magnetic resonance imaging 3 days after surgery. Secondary endpoints will include the prevalence of new focal neurological deficits in the first 7 days after surgery, the occurrence of postoperative cognitive dysfunction at either 1 week or 3 months after surgery and the incidence of delirium in the first 7 days after surgery. Data will be analysed on intention-to-treat principles and a per protocol basis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elective and/or urgent coronary artery bypass

Exclusion criteria

  • emergent and salvage setting
  • score below age- and education-adjusted cut-off scores in mini mental state examination
  • score above 8 on the subscales of hospital anxiety and depression scale
  • neurologic deficit of any etiology
  • previous psychiatric illness
  • use of tranquilizers or antipsychotics
  • alcohol or drug abuse
  • history of cardiac surgery
  • left ventricular ejection fraction less than 30%
  • extracranial carotid artery stenosis of more than 70%
  • body mass index of more than 35 kg/m2
  • any contraindication for magnetic resonance imaging (e.g., magnetic resonance imaging - incompatible implantable device and claustrophobia)

Treatment and study plan

aortic no-touch OPCABG

Procedure

(Study arm 1) In this intervention only the internal mammary artery grafts will be used (i.e. left internal mammary artery graft, right internal mammary artery graft, or a Y-graft that uses right internal mammary artery graft anastomosed onto left internal mammary artery graft to allow for a wide territory of myocardial revascularization). However, in the rare event that the aforementioned approach is insufficient to reach all target vessels, a reversed (great) saphenous vein graft may be used to extend the left internal mammary artery graft or the right internal mammary artery graft.

OPCABG with partial clamp applying carbon dioxide

Procedure

(Study arm 2) In this intervention chest cavity will be insufflated with carbon dioxide at a flow above 5 l/min during the entire surgical procedure.

OPCABG with partial clamp

Procedure

(Study arm 3) This is the control arm undergoing "traditional" OPCABG with partial clamp.

Primary outcomes

  1. New lesions on control brain magnetic resonance imaging.

    Time frame: 3 days after surgery

    Appearance of new lesions on control brain magnetic resonance imaging 3 days after surgery.

Secondary outcomes

  1. New focal neurological deficits.

    Time frame: 7 days after surgery

    Prevalence of new focal neurological deficits in the first 7 days after surgery.

  2. Occurence of postoperative cognitive dysfunction

    Time frame: 1 week or 3 months after surgery

    Occurrence of postoperative cognitive dysfunction at either 1 week or 3 months after surgery

  3. Incidence of delirium

    Time frame: 7 days after surgery

    Incidence of delirium in the first 7 days after surgery.

Sponsors and collaborators

Lead sponsor

Collegium Medicum w Bydgoszczy

Other

Registry information

Acronym: CANON

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 9, 2017
Registry last updated
Feb 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.